List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Chlamydia Infections - Overview
Chlamydia Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Chlamydia Infections - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Chlamydia Infections - Companies Involved in Therapeutics Development
Abera Bioscience AB
Abivax SA
BlueWillow Biologics Inc
Erganeo
Evofem Biosciences Inc
Genetic Immunity Inc
Lawrence Livermore National Laboratory
Lead Discovery Center GmbH
Merck & Co Inc
Microbiotix Inc
Prokarium Ltd
QureTech Bio AB
Vault Pharma Inc
Vaxine Pty Ltd
Yaso Therapeutics Inc
Chlamydia Infections - Drug Profiles
Ab-03 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ABX-196 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Amphora - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ChlamyDerm - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia trachomatis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PEG-2S - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Peptide to Inhibit CPAF for Chlamydia Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PPCM - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for Chlamydia Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Block Virulence for Chlamydia Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit 16S rRNA for Gonorrhea and Chlamydia Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
solithromycin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VPI-201 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chlamydia Infections - Dormant Projects
Chlamydia Infections - Product Development Milestones
Featured News & Press Releases
Aug 13, 2019: Progress made in developing first Chlamydia vaccine
Sep 26, 2018: BlueWillow Biologics awarded grant for chlamydia vaccine development
Apr 20, 2017: New weapon in fight against antibiotic resistance discovered
Dec 02, 2015: NanoBio’s Chlamydia Vaccine Improves Clearance of Bacteria and Prevents Pelvic Inflammatory Disease in Mice
Aug 03, 2015: New Vaccine For Chlamydia to Use Synthetic Biology
Aug 03, 2015: SynbiCITE funds new vaccine for Chlamydia
Aug 12, 2014: Cempra Initiates Phase 3 Clinical Trial in Patients With Uncomplicated Gonorrhea Infection
Jul 20, 2011: Newly Designed Molecule Blocks Chlamydia Bacteria
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Chlamydia Infections, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Chlamydia Infections - Pipeline by Abera Bioscience AB, H1 2020
Chlamydia Infections - Pipeline by Abivax SA, H1 2020
Chlamydia Infections - Pipeline by BlueWillow Biologics Inc, H1 2020
Chlamydia Infections - Pipeline by Erganeo, H1 2020
Chlamydia Infections - Pipeline by Evofem Biosciences Inc, H1 2020
Chlamydia Infections - Pipeline by Genetic Immunity Inc, H1 2020
Chlamydia Infections - Pipeline by Lawrence Livermore National Laboratory, H1 2020
Chlamydia Infections - Pipeline by Lead Discovery Center GmbH, H1 2020
Chlamydia Infections - Pipeline by Merck & Co Inc, H1 2020
Chlamydia Infections - Pipeline by Microbiotix Inc, H1 2020
Chlamydia Infections - Pipeline by Prokarium Ltd, H1 2020
Chlamydia Infections - Pipeline by QureTech Bio AB, H1 2020
Chlamydia Infections - Pipeline by Vault Pharma Inc, H1 2020
Chlamydia Infections - Pipeline by Vaxine Pty Ltd, H1 2020
Chlamydia Infections - Pipeline by Yaso Therapeutics Inc, H1 2020
Chlamydia Infections - Dormant Projects, H1 2020

List of Figures
Number of Products under Development for Chlamydia Infections, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Targets, H1 2020
Number of Products by Stage and Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020

Companies Mentioned
• Abera Bioscience AB
• Abivax SA
• BlueWillow Biologics Inc
• Erganeo
• Evofem Biosciences Inc
• Genetic Immunity Inc
• Lawrence Livermore National Laboratory
• Lead Discovery Center GmbH
• Merck & Co Inc
• Microbiotix Inc
• Prokarium Ltd
• QureTech Bio AB
• Vault Pharma Inc
• Vaxine Pty Ltd
• Yaso Therapeutics Inc